Loading...
A new guideline covers virtually all nonpharmacologic and pharmacologic facets of primary prevention of cardiovascular (CV) disease.
Lifestyle modification — including diet, exercise, and smoking cessation — is emphasized heavily, regardless of drug therapy use.
Recommendations for lipid management duplicate the primary prevention sections of the 2018 ACC/AHA cholesterol guideline (NEJM JW Gen Med Feb 1 2019 and J Am Coll Cardiol 2018 Nov 10; [e-pub]). The new category of “intermediate” 10-year CV risk (7.5%–20%) gives clinicians leeway in individualizing decisions to prescribe statins. That broad category presumably was crea…